Publications en collaboration avec des chercheurs de Vall d'Hebron Institut de Recerca (67)

2024

  1. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Scientific reports, Vol. 14, Núm. 1, pp. 3000

  2. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

  3. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 9

  4. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 8

  5. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

  6. Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial

    Injury, Vol. 55, Núm. 11

  7. New developments in infective endocarditis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 9, pp. 779-787

  8. Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial

    International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126

  9. Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)

    Injury, Vol. 55, Núm. 10

  10. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  11. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

  12. Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 5, pp. 410-418

  13. SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population

    Database : the journal of biological databases and curation, Vol. 2024

  14. Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuum

    International Journal of Infectious Diseases, Vol. 146

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of Endovascular Thrombectomy vs Medical Management with Functional and Safety Outcomes in Patients Treated beyond 24 Hours of Last Known Well: The SELECT Late Study

    JAMA Neurology, Vol. 80, Núm. 2, pp. 172-182

  3. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy

    Frontiers in Aging Neuroscience, Vol. 15

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations

    PloS one, Vol. 18, Núm. 7, pp. e0287515

  6. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215